Fulcrum Therapeutics 10% owner Kevin Tang reports buying $892,170 of common shares - FULC News | RalliesFulcrum Therapeutics 10% owner Kevin Tang reports buying $892,170 of common shares
F
FULC• Kevin Tang discloses open-market purchases
- Tang Capital’s Kevin Tang, a 10% owner, disclosed open-market purchases of 250,000 Fulcrum Therapeutics common shares.
- Holdings rose to 6,913,329 shares through Tang-managed entities.
- Purchases were priced around USD 3.54 to USD 3.58 per share.
•
